Catalyst Wire Dossier Catalyst Wire Dossier

Opevesostat (MK-5684)

opevesostat · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opevesostat (MK-5684), covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: A Drug-Drug Interaction Study of Carbamazepine and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-012) [Phase 1]

See pricing